Impact of bridging chemotherapy on clinical outcome of CD19 CAR T therapy in adult acute lymphoblastic leukemia.

Authors :: Perica K
Flynn J
Curran KJ
Rivere I
Wang X
Senechal B
Halton E
Diamonte C
Pineda J
Bernal Y
Gonen M
Sadelain M
Brentjens RJ
Park JH
Source :: Leukemia [Leukemia] 2021 Nov; Vol. 35 (11), pp. 3268-3271. Date of Electronic Publication: 2021 Mar 08.
Publication Year :: 2021

Subjects :: Adult
Combined Modality Therapy
Humans
Precursor Cell Lymphoblastic Leukemia-Lymphoma immunology
Precursor Cell Lymphoblastic Leukemia-Lymphoma pathology
Prognosis
Survival Rate
Antigens, CD19 immunology
Antineoplastic Combined Chemotherapy Protocols therapeutic use
Immunotherapy, Adoptive mortality
Precursor Cell Lymphoblastic Leukemia-Lymphoma therapy

Full Text Access

Tools